A Pennsylvania medical company is set to begin clinical trials for a new adhesive they say could improve the safety and efficacy of cosmetic surgeries like the tummy tuck.
Cohera Medical calls the new product TissuGlu®, and recently announced plans to move forward with clinical trials this November. As explained in a recent press release, the adhesive bonds flaps of tissue together during tummy tuck surgery to reduce fluid accumulation and thereby, the chance of complications.
Most tummy tuck surgeries require placement of a special drain to remove fluid. A method that uses surgical adhesive could, in theory, make drains unnecessary.
Cohera Medical CEO Patrick Daly explains, “This unique product will ultimately help surgeons address a critical need and improve patient care.” In Germany, as many as 40 patients are expected to be enrolled in clinical trials to investigate TissuGlu’s safety and efficacy.
About Abdominoplasty
The tummy tuck is a common cosmetic procedure designed to reduce the appearance of a protruding abdomen, whether it is due to weight fluctuations, pregnancy, or aging. See our homepage to learn more about how Dr. Edds performs this procedure right here in Owensboro, Kentucky.
Pharmaceutical company Allergan Inc., has filed suit against the FDA, arguing that restrictions placed on the marketing of 
